TAK Takeda Pharmaceutical Co Ltd ADR
Health Care > Pharmaceuticals, Biotechnology & Life Sciences > Pharmaceuticals > Pharmaceuticals | NYSE, LargeCap, BiotechHealthcare | Last Price: 18.75 | 2026-02-27 | Atrp: 1.41
Sat 21 Feb 2026 to Fri 27 Feb 2026: Score 6
| Metric | Previous | New | Change | Interpretation | |
|---|---|---|---|---|---|
| â | Price Book MRQ | 1.1697 | 0.9832 | ▼ -15.94% | Bullish. Lower is better. Closer to 1; less undervalued on assets but improved perception Stock price divided by book value per share for the most recent quarter |
| â | Enterprise Value/Revenue | 2.9027 | 2.4267 | ▼ -16.4% | Bullish. Lower is better. Moderate improvement Enterprise value divided by revenue |
| â | Short Ratio | 2.4 | 1.85 | ▼ -22.92% | Bullish. Lower is better. Significant improvement |
| â | Short Percent | 0.25% | 0.21% | ▼ -16% | Bullish. Lower is better. Moderate decrease; still high, potential for squeeze if positive catalysts emerge Percentage of shares sold short |
| â | Enterprise Value/EBITDA | 10.4183 | 9.6668 | ▼ -7.21% | Bullish. Lower is better. Slight improvement Enterprise value to earnings before interest, taxes, depreciation |
| â | PEG Ratio | 0.3978 | 0.4185 | ▲ 5.2% | Bearish. Lower is better. Slight increase, worsening the value relative to growth P/E ratio adjusted for growth rate |
| â | Forward PE | 12.7714 | 14.2653 | ▲ 11.7% | Bearish. Lower is better. Moderate decline Stock price divided by expected future earnings |
| â | Enterprise Value | $84.78B | $73.91B | ▼ -12.82% | Bearish. Higher is better. Decreased, reflecting lower market cap and possibly debt adjustments Market capitalization plus debt minus cash |
Fri 13 Feb 2026 to Sat 21 Feb 2026: Score -2
| Metric | Previous | New | Change | Interpretation | |
|---|---|---|---|---|---|
| â | Wall Street Target Price | 19.1212 | 18.8959 | ▼ -1.18% | Bearish. Higher is better. Lower analyst expectations, pointing to decreased optimism for future performance Analysts' consensus target price for the stock |
| â | Book Value | 31.5666 | 31.1796 | ▼ -1.23% | Bearish. Higher is better. Slight decrease; stock now trades further from book value Net asset value of the company per share |
| â | Price Sales TTM | 0.013 | 0.0132 | ▲ 1.54% | Bearish. Lower is better. Higher multiple; market willing to pay more per dollar of sales Stock price divided by revenue per share over the trailing twelve months |
| â | Enterprise Value | $83.83B | $84.78B | ▲ 1.14% | Bullish. Higher is better. Increased, reflecting higher market cap and possibly debt adjustments Market capitalization plus debt minus cash |
Thu 29 Jan 2026 to Thu 05 Feb 2026: Score 28
| Metric | Previous | New | Change | Interpretation | |
|---|---|---|---|---|---|
| â | Quarterly Earnings Growth YOY | 311% | 3301% | ▲ 982.62% | Bullish. Higher is better. Quarterly earnings growth YOY growth accelerating. Year-over-year growth in quarterly earnings |
| â | Profit Margin | 0.75% | 2.53% | ▲ 237.33% | Bullish. Higher is better. Profit margin growth accelerating. Percentage of revenue that turns into profit |
| â | Return On Equity TTM | 0.47% | 1.5% | ▲ 219.15% | Bullish. Higher is better. Return on equity TTM growth accelerating. Efficiency in generating profits from shareholders' equity |
| â | Quarterly Revenue Growth YOY | -51% | 41% | ▲ 177.78% | Bullish. Higher is better. Quarterly revenue growth YOY turned from decline to growth; signs of recovery. Year-over-year growth in quarterly revenue |
| â | EBITDA | $1138373.03M | $1273957.06M | ▲ 11.91% | Bullish. Higher is better. Increase in earnings before interest, taxes, depreciation, and amortization; indicates stronger operational cash flow Earnings before interest, taxes, depreciation, and amortization |
| â | Return On Assets TTM | 2.09% | 2.47% | ▲ 18.18% | Bullish. Higher is better. Return on assets TTM growth accelerating. Efficiency in generating profits from total assets |
| â | Enterprise Value/EBITDA | 11.4663 | 10.2583 | ▼ -10.54% | Bullish. Lower is better. Moderate improvement Enterprise value to earnings before interest, taxes, depreciation |
| â | Book Value | 29.4826 | 30.8312 | ▲ 4.57% | Bullish. Higher is better. Slight increase; stock now trades closer to book value Net asset value of the company per share |
| â | Enterprise Value | $78.26B | $81.9B | ▲ 4.64% | Bullish. Higher is better. Increased, reflecting higher market cap and possibly debt adjustments Market capitalization plus debt minus cash |
| â | Gross Profit TTM | $2862113.88M | $2925414.06M | ▲ 2.21% | Bullish. Higher is better. Slight increase, but margins may be improving Revenue minus cost of goods sold over the trailing twelve months |
| â | Revenue TTM | $4417004.24M | $4464578.13M | ▲ 1.08% | Bullish. Higher is better. Slight top-line expansion Total revenue over the trailing twelve months |
| â | Revenue Per Share TTM | 1400.906 | 1417.2314 | ▲ 1.17% | Bullish. Higher is better. Slight improvement Revenue generated per outstanding share over the trailing twelve months |
| â | Wall Street Target Price | 19.0311 | 18.6652 | ▼ -1.92% | Bearish. Higher is better. Lower analyst expectations, pointing to decreased optimism for future performance Analysts' consensus target price for the stock |
| â | Price Sales TTM | 0.0123 | 0.0126 | ▲ 2.44% | Bearish. Lower is better. Higher multiple; market willing to pay more per dollar of sales Stock price divided by revenue per share over the trailing twelve months |
| â | Institutional Ownership | 2.714% | 2.678% | ▼ -1.33% | Bearish. Higher is better. Slight decline; reduced interest from big investors Percentage held by institutions like mutual funds |
| â | PEG Ratio | 0.3587 | 0.3896 | ▲ 8.61% | Bearish. Lower is better. Slight increase, worsening the value relative to growth P/E ratio adjusted for growth rate |
| â | Forward PE | 11.5207 | 12.5 | ▲ 8.5% | Bearish. Lower is better. Slight decline Stock price divided by expected future earnings |
| â | Enterprise Value/Revenue | 2.7016 | 2.8581 | ▲ 5.79% | Bearish. Lower is better. Slight decline Enterprise value divided by revenue |
| â | Operating Margin TTM | 15.29% | 10.85% | ▼ -29.04% | Bearish. Higher is better. Operating margin TTM growth slowing. Percentage of revenue left after operating expenses |
Thu 22 Jan 2026 to Thu 29 Jan 2026: Score 12
| Metric | Previous | New | Change | Interpretation | |
|---|---|---|---|---|---|
| â | Earnings Per Share | 0.07 | 0.23 | ▲ 228.57% | Bullish. Higher is better. Extreme increase in earnings per share Profit allocated to each outstanding share |
| â | Short Ratio | 4.31 | 3.78 | ▼ -12.3% | Bullish. Lower is better. Moderate improvement |
| â | Wall Street Target Price | 17.6477 | 19.0311 | ▲ 7.84% | Bullish. Higher is better. Higher analyst expectations, pointing to increased optimism for future performance Analysts' consensus target price for the stock |
| â | Enterprise Value | $74.37B | $78.26B | ▲ 5.23% | Bullish. Higher is better. Increased, reflecting higher market cap and possibly debt adjustments Market capitalization plus debt minus cash |
| â | Short Percent | 0.33% | 0.31% | ▼ -6.06% | Bullish. Lower is better. Slight decrease; still high, potential for squeeze if positive catalysts emerge Percentage of shares sold short |
| â | Book Value | 28.485 | 29.4826 | ▲ 3.5% | Bullish. Higher is better. Slight increase; stock now trades closer to book value Net asset value of the company per share |
| â | Price Sales TTM | 0.012 | 0.0123 | ▲ 2.5% | Bearish. Lower is better. Higher multiple; market willing to pay more per dollar of sales Stock price divided by revenue per share over the trailing twelve months |
| â | Price Book MRQ | 1.1267 | 1.1413 | ▲ 1.3% | Bearish. Lower is better. Further to 1; more overvalued on assets but worsened perception Stock price divided by book value per share for the most recent quarter |
| â | Enterprise Value/Revenue | 2.663 | 2.7016 | ▲ 1.45% | Bearish. Lower is better. Slight decline Enterprise value divided by revenue |
| â | Enterprise Value/EBITDA | 11.3024 | 11.4663 | ▲ 1.45% | Bearish. Lower is better. Slight decline Enterprise value to earnings before interest, taxes, depreciation |
Wed 14 Jan 2026 to Thu 22 Jan 2026: Score -7
| Metric | Previous | New | Change | Interpretation | |
|---|---|---|---|---|---|
| â | EPS Estimate Current Year | 73.969 | 51.162 | ▼ -30.83% | Bearish. Higher is better. Significant decrease; reduced outlook for current year earnings Expected earnings per share this year |
| â | EPS Estimate Next Year | 122.171 | 109.66 | ▼ -10.24% | Bearish. Higher is better. Moderate lowered expectations for further out Expected earnings per share next year |
Tue 06 Jan 2026 to Wed 14 Jan 2026: Score -1
| Metric | Previous | New | Change | Interpretation | |
|---|---|---|---|---|---|
| â | PEG Ratio | 0.3444 | 0.3566 | ▲ 3.54% | Bearish. Lower is better. Slight increase, worsening the value relative to growth P/E ratio adjusted for growth rate |
| â | Wall Street Target Price | 17.8497 | 17.5062 | ▼ -1.92% | Bearish. Higher is better. Lower analyst expectations, pointing to decreased optimism for future performance Analysts' consensus target price for the stock |
| â | Forward PE | 11.0619 | 11.4416 | ▲ 3.43% | Bearish. Lower is better. Slight decline Stock price divided by expected future earnings |
| â | Price Sales TTM | 0.0118 | 0.0121 | ▲ 2.54% | Bearish. Lower is better. Higher multiple; market willing to pay more per dollar of sales Stock price divided by revenue per share over the trailing twelve months |
| â | Price Book MRQ | 1.0825 | 1.1208 | ▲ 3.54% | Bearish. Lower is better. Further to 1; more overvalued on assets but worsened perception Stock price divided by book value per share for the most recent quarter |
| â | Enterprise Value/Revenue | 2.6133 | 2.6795 | ▲ 2.53% | Bearish. Lower is better. Slight decline Enterprise value divided by revenue |
| â | Enterprise Value/EBITDA | 11.0914 | 11.3722 | ▲ 2.53% | Bearish. Lower is better. Slight decline Enterprise value to earnings before interest, taxes, depreciation |
| â | Enterprise Value | $73.63B | $74.9B | ▲ 1.72% | Bullish. Higher is better. Increased, reflecting higher market cap and possibly debt adjustments Market capitalization plus debt minus cash |
| â | Short Ratio | 4.51 | 4.31 | ▼ -4.43% | Bullish. Lower is better. Slight improvement |
| â | Short Percent | 0.37% | 0.33% | ▼ -10.81% | Bullish. Lower is better. Moderate decrease; still high, potential for squeeze if positive catalysts emerge Percentage of shares sold short |
Sat 20 Dec 2025 to Tue 06 Jan 2026: Score -14
| Metric | Previous | New | Change | Interpretation | |
|---|---|---|---|---|---|
| â | Short Ratio | 3.47 | 4.51 | ▲ 29.97% | Bearish. Lower is better. Significant decline |
| â | PEG Ratio | 0.3269 | 0.3444 | ▲ 5.35% | Bearish. Lower is better. Slight increase, worsening the value relative to growth P/E ratio adjusted for growth rate |
| â | Forward PE | 10.4932 | 11.0619 | ▲ 5.42% | Bearish. Lower is better. Slight decline Stock price divided by expected future earnings |
| â | Price Sales TTM | 0.0112 | 0.0118 | ▲ 5.36% | Bearish. Lower is better. Higher multiple; market willing to pay more per dollar of sales Stock price divided by revenue per share over the trailing twelve months |
| â | Price Book MRQ | 1.0265 | 1.0825 | ▲ 5.46% | Bearish. Lower is better. Further to 1; more overvalued on assets but worsened perception Stock price divided by book value per share for the most recent quarter |
| â | Enterprise Value/Revenue | 2.5307 | 2.6133 | ▲ 3.26% | Bearish. Lower is better. Slight decline Enterprise value divided by revenue |
| â | Enterprise Value/EBITDA | 10.7408 | 11.0914 | ▲ 3.26% | Bearish. Lower is better. Slight decline Enterprise value to earnings before interest, taxes, depreciation |
| â | Short Percent | 0.36% | 0.37% | ▲ 2.78% | Bearish. Lower is better. Slight increase; still high, potential for squeeze if positive catalysts emerge Percentage of shares sold short |
| â | Enterprise Value | $71.83B | $73.63B | ▲ 2.51% | Bullish. Higher is better. Increased, reflecting higher market cap and possibly debt adjustments Market capitalization plus debt minus cash |